Trial intelligence / Profile preview

RELAX: Rocuronium in Hypothermic Patients After Cardiac Arrest

NCT01719770Phase 3Completed

Sponsor
Medical University of Vienna
Start
Nov 2010
Primary completion
Oct 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial comparing Rocuronium with Placebo (2 arms). Primary endpoint: Number of shivering episodes at 31 hours. Started Nov 2010; status: completed.

02

Drugs

rocuronium

Beyond the preview

Go deeper on NCT01719770.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01719770.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call